Emerging Therapies Drive Analytical Advancements.

The article focuses on how the emergence of messenger ribonucleic acid (mRNA) vaccines and cell and gene therapies is driving advancements in analytical methods in the bio/pharmaceutical industry. Topics discussed include the adoption of new technologies like long-read sequencing and high-resolution analytical techniques, considerations for assay development for new modalities, and the role of artificial intelligence (AI) and machine learning (ML) in biopharma analysis.